جستجوی مقالات مرتبط با کلیدواژه "chondrosarcoma" در نشریات گروه "پزشکی"

 Osteochondroma is a benign tumor of bone. Malignant transformation of Osteochondroma is the most devastating complication one can encounter. Osteochondroma can transform into any malignancy like Osteosarcoma, Chondrosarcoma and Ewing sarcoma. Malignant transformation is more common in patients with multiple exostosis. Recognition of this malignant transformation is needed to predict the patient's outcome.

  A 26-year-old male patient came with complaints of a mass in the left knee region for the past 7 years. X-ray of the knee showed multiple pedunculated exostosis on either side of the distal end of the femur, tibia and fibula. Histopathological examination revealed a bony lesion with a cartilaginous cap of increased thickness and cellularity. The cartilaginous cap possesses plump chondrocytes showing binucleation-forming nodules with mild atypia. The cartilaginous cap undergoes endochondral ossification, suggesting the possibility of a secondary peripheral atypical cartilaginous tumor from osteochondroma of the tibia.

 Chondrosarcoma is a heterogeneous type of primary bone cartilaginous malignancy with variable clinical outcomes. Malignant transformation of osteochondroma in the appendicular skeleton was named atypical cartilaginous tumor; in the axial skeleton, it is named Grade 1 Chondrosarcoma.

 Differentiation between osteochondroma and its malignant transformation can be possible if made in a multidisciplinary setting such as clinical history, radiological findings along with histology to confirm the diagnosis.

Intracranial chondroma and chondrosarcoma are very rare tumors that mainly originate from the base of the skull. Advanced neuroimaging studies, including magnetic resonance spectroscopy (MRS), play a pivotal role in both tumor diagnosis and presurgical planning.

We present two cases of intracranial cartilaginous tumors, including a chondroma and a chondrosarcoma, both of which presented with severe headaches. Due to inconclusive conventional MRI and MRS results, they were both primarily diagnosed as intra-axial brain tumors. However, pathological reports later confirmed the diagnosis of a chondroma and a chondrosarcoma.

Based on the present findings, the use of advanced neuroimaging techniques, such as MRS, may improve diagnostic accuracy. We believe that MRS can play a significant role in the surgical planning of similar cases. Also, reporting rare cases worldwide can contribute to the improvement of radiographic diagnosis.

The number of available musculoskeletal tumor registries is relatively small. We developed a registry system focused on the clinical aspects of musculoskeletal tumors to improve quality of care indexes through the development of updated national protocols. In this study, we describe our protocol, challenges, and the data collected during the implementation of the registry system in a single-specialty orthopedic center in Iran.  

Three main malignant bone tumors, including osteosarcoma, Ewing sarcoma, and chondrosarcoma, were included in the registry. After establishing a steering committee, we defined the minimum data set based on a literature review and suggestions from an expert panel. Accordingly, the data collection forms and the web-based software were developed. The collected information was categorized into 9 classes, including demographics, socioeconomic data, signs and symptoms, past medical history, family history, laboratory tests, tumor characteristics, primary treatment, and follow-up. Data collection was performed both retrospectively and prospectively.  

Until September 21, 2022, a total of 71 patients were registered (21 patients prospectively and 50 patients retrospectively) and consisted of 36 (50.7%) cases of osteosarcoma, 13 (18.3%) cases of Ewing sarcoma, and 22 (31%) cases of chondrosarcoma. The implementation of the registry demonstrated promising data regarding the tumor characteristics, delay patterns, and socioeconomic status of the patients. 

The main lessons learned were to develop a monitoring system to make sure that the new staff is adequately trained for the registration process as well as avoid the inclusion of time-consuming useless data in the minimum data set.

Chondrosarcoma is regarded as the second most common primary bone malignancy following osteosarcoma.

The present study aimed at determining the epidemiology, incidence, and survival rate of chondrosarcoma in the Iranian population, according to the Iran National Cancer Registry (INCR).

In an epidemiological study, patients with limb chondrosarcoma were evaluated based on INCR data between 2008 and 2015. Data included patients’ demographic characteristics, date of diagnosis, location of the tumor, patient’s survival, and type of tumor based on the International Classification of Diseases for Oncology (ICD-O-3; first revision, third edition) were collected and analyzed.

Out of 732 enrolled patients, 425 patients (58.06%) were male and 307 (41.94%) were female with a mean age of 44.08 (SD = 19.31) and 45.06 (SD = 18.72), respectively. Age-standardized incidence rates (ASIR) were 1.73 and 1.27 per 1 million person-years for males and females, respectively. Conventional chondrosarcoma was the most common subtype with ASIR 1.28 and constituted 84.7% of patients with chondrosarcoma. About 71.03% of all Chondrosarcoma patients (70.35% of males and 71.99% of females) were between 20 to 59 years old. The 1-, 3-, 5-, and 7-year survival rates of patients were 0.87, 0.73, 0.57, and 0.47, respectively. Also, the mean survival time was 6.12 years (95% CI: 5.85 - 7.39).

The incidence of chondrosarcoma in Iran is not as high as in other countries, but as patients are younger in Iran, the survival rate is worse compared to other countries. Therefore, better case findings and better care are needed to improve the patients' outcomes in Iran.

Squamous cell carcinoma (SCC) is the most prevalent malignancy of the larynx. Non-squamous cell carcinomas of the larynx are rare and consist of different pathology types. The present work is a retrospective study of non-SCC of the larynx in the south of Iran during a seven-year period. Among 517 patients with laryngeal cancers, seven (0.13%) had non-SCC. The mean age was 59.1 (39-71) years, and six were male. The main complaint of two of the patients was neck mass, five cases had hoarseness, and one had dyspnea. One subject had both dyspnea and hoarseness. Out of three cases of neuroendocrine tumor, two had radical surgery and afterwards, radiotherapy (RT) was given for one of them. Both cases are well and disease-free. The other patient was a 58-year-old man and was treated with chemoradiation. He died due to brain metastasis following 12 months. Our patient with osteosarcoma is well controlled with surgery, chemotherapy, and RT. We had two male cases of adenoid cystic carcinoma who had undergone total laryngectomy and supraglottic laryngectomy. Both of them received RT (60 or 70 Gy dose) and both are well after 60 and 48 months. A 51-year-old patient with chondrosarcoma had undergone total laryngectomy, who was well after 36 months. Treatment of non-SCC of the larynx is an extrapolation from the treatment of the more common site of each pathology type. Further studies are needed to draw a firm conclusion.

Chondrosarcoma of the cranium is a rare malignancy. The result of treatment is challenging to assess because the slow-growing rate means that there is a long interval previously discovering the recurrence and last long time to diagnosis of recurrence. This report describes a 38-year-old man who presented with a generalized seizure 2 months before his referral. The patient underwent excisional surgery. The histological examinations revealed a cartilage developing tumor compatible with chondrosarcoma. The radiologic and histologic correlation established the diagnosis. But, the patient had two episodes of recurrence after surgery. We determined that intracranial chondrosarcoma must be comprised in the differential diagnosis of a mass with calcification on cranial imaging. Accurate diagnosis is obligatory for supplementary patient managing, and a recurrence is more common in patients only treated by surgery.

Tracheal chondrosarcoma (TCS) is a rare malignancy, with only 19 cases described in the literature to date.

Herein, we presented the third-largest TCS with such an airway compromise that neither orotracheal intubation nor jet ventilation or even tracheostomy was possible. So, extracorporeal circulation was needed to excise the tumor in a one- stage procedure. The patient presented no tumor recurrences after surgery during an approximate7-years follow-up. So open surgical resection and end-to-end anastomosis probes may be applied as a safe and successful treatment. A review of the previous literature revealed no extracorporeal circulation in previous practices.

Management of tracheal chondrosarcoma is challenging due to its airway compromise during the procedure. Different treatment modalities have been advised but none of them included extracorporeal circulation as an option. We believe that this approach allows for better control of the resection and ensures better oxygenation of the patient.

  Chondrosarcomas (CS) are malignant mesenchymal tumours with cartilaginous differentiation that rarely affects the maxillofacial region. It accounts for approximately 10-20% of malignant bone tumours.  The CS is rare in occurrence with aggressive course with high malignant potential, and poor prognosis.

Case Report:

Here we report a rare case of a 37year old female presenting tumoral mass in the lower jaw, for the past 3 years, which was gradually progressive in nature with an area of skin ulceration. The CT revealed a well- defined lesion with soft tissue component measuring 15x12x10 cm in size infiltrating both right and left masseter. Biopsy confirmed the diagnosis of grade IIICS. Considering the size and aggressive nature of the lesion, surgical resection was done. The reconstruction of the mandible was done with vascularised fibula pedicle flap to achieve acceptable cosmesis. The patient was discharged uneventfully. Though few cases of high grade CS have been reported in literature but CS of this enormous size has not been reported yet.

In this case report we documented the management of a relatively rare but challenging reconstructive maxillofacial surgery.  Since in this case the CS was enormous in size and aggressive surgery was required, the cosmetic and functional outcomes were challenging. In our case report we have found that a vascularised fibula pedicle flap gives a good functional and cosmetic outcome and can be used for reconstruction of complete mandible.

Chondrosarcoma is a rare tumor of the head and neck with a prevalence of 5-12% of all chondrosarcomas reported. The most common affected site in the head and neck is the larynx. Other sites include the craniofacial, maxilla, and mandible, nasal cavity, and paranasal sinuses. Clinical symptoms usually include a painless mass with bony swelling and one of the symptoms that thepatient presents with is epistaxis nasal obstruction. The most appropriate treatment is radical surgery. This article introduces a 72-year-old man with a complaint of left nasal congestion, epistaxis, and swelling of middle canthus area of the left eye.

Chondrosarcoma is one of the common malignant bone tumors and is characterized by thin tumors. The cells produce tumor cartilage. It occur usually 3rd decade of life, affected more men than women.

To perform alternate surgical procedures for remove tumor and obtain fully forearm functionality by reconstruction. 

A patient affected by a rare proximal radius chondrosarcoma bone tumor and it became malignant (grade III). Resection the tumor along with chemotherapy and radiotherapy was done. Surgical treatments are mainly recommended for most types of chondrosarcoma treatment. However, the treatment of chondrosarcoma clinically and surgically is controversial due to different techniques.

Patients was fully recovered with excellent wrist and elbow joint functionality. Reconstruction of bones were fused by the support of metallic implants. There was no tumor recurrence occur during post-operative follow-up period.

Chondrosarcoma of bone generally has an excellent prognosis when optimal diagnosed and treated by an experienced team of specialists. Its clinical treatment is always challenging due to of the rarity of these lesions and few institutions having enough patients to study about it.

The metastasis to respiratory system secondary to chondrosarcoma is a common finding; however, metastasis to other organs such as skin or bones is much less common. In the current report, we described a case with the history of chondrosarcoma of the mandible that recently referred with the metastatic lesions in her scalp skin. Our case is a female patient that its secondary metastasis occurred only 4 months after her initial tumor diagnosis. More interestingly, among all baseline laboratory parameters, only inflammatory biomarkers increased as the nonspecific diagnostic indices. In other words, the accurate diagnosis of metastasis to bone following chondrosarcoma may be delayed and even masked with early inflammatory reactions. On the whole, in all patients who suffer from chondrosarcoma, early metastasis to skin or bones should be considered, especially when inflammatory indices are high.

Imaging knowledge regarding retroperitoneal primary extraskeletal mesenchymal chondrosarcoma (ESMC) is limited. We report a new case of ESMC originated from the retroperitoneum. The tumor was indicated a well-defined mass with marker calcification, the parenchyma showed gradual enhancement pattern on the biphasic enhanced computed tomography and wash-in-wash-out enhancement pattern on the contrast-enhanced magnetic resonance imaging and hyperintensity on diffusion-weighted imaging which implying the dense cellularity of tumor cells. Sonography indicated an increased echogenicity nodular area in the mass. These imaging features further enriched the imaging knowledge of this rare tumor and presented valuable imaging characteristics to diagnose retroperitoneal primary ESMC.

Laryngeal chondrosarcoma is a rare tumor that involves head and neck region such as larynx in rare cases. This malignant tumor usually grows quite slowly. The patient may experience symptoms for several years before a diagnosis is made. The diagnosis is achieved by clinical, radiological and pathological features. Management is basically surgical. Prognosis is generally good, depending basically on histologic grade. Herein, we report a case of laryngeal chondrosarcoma presented with hoarseness. Spiral CT scan demonstrated an expansile mass with calcification originating from cricoid cartilage. The patient underwent surgery for open excisional biopsy, and postoperative histopathologic evaluations confirmed "laryngeal chondrosarcoma" as definite diagnosis. The patient denied total laryngectomy for complete removal of the tumor. Six months follow up showed no more growth.

Clavicular bone tumors occur in less than 0.5 percent of bone tumors. Primary chondrosarcoma is very rare even among clavicle tumors. The main symptom is a touchable mass in 69 % of patients. Dedicated centers using FNA and cytology can reach a correct diagnosis in 94% of cases. Treatment planning is done using simple X-ray, CT-scan, shoulder MRI, chest CT-scan, and whole body technetium scan. Treatment of choice for primary chondrosarcoma of clavicle is surgical resection.

Chondrosarcoma is a mesenchymal tumor composed of tumor cells producing cartilage. It is more common in older age and often affects the axial skeleton. We report a rare case of chondrosarcoma mimicking a sellar and suprasellar mass with parasellar extension. A 40 yr woman presented with decreasing visual acuity and headache. Magnetic resonance (MR) image revealed a cystic sellar and suprasellar mass with parasellar extension showing mild enhancing solid component. It favored the diagnosis of craniopharyngioma. The patient underwent trans-sphenoidal partial resection of the tumor resulting in removal of the sellar mass. However, the suprasellar mass could not be excised completely due to limited surgical field. The pathologic diagnosis was chondrosarcoma. Eight months after the operation, pterional approach was performed to remove the remaining mass. Intraoperative findings confirmed that the mass originated from dorsum sellae.

Breast Sarcomas have relatively been rare and accounted for 1% of all primary malignant tumors of the breast. Pure and primary chondrosarcoma of the male breast would be an extremely rare tumor. It might arise either from the breast stroma itself, or from underlying bone or cartilage. A 65-year-old man has presented with a rapidly growing breast mass since 5 months. Physical examination has established a large firm to hard mass with regular margins in the region of right breast. There was no axillary lymphadenopathy. Contrast enhanced MRI of breasts has shown a mixed-signal intensity multi lobulated cystic-solid mass (10.4 cm × 10.3 cm ×9.9 cm) appearing predominantly hyper intense on T2W and hypo intense on T1W. The tumor has diagnosed as a low-grade chondrosarcoma of the breast by histopathological and immunohistochemistry analysis. Right sided radical mastectomy with grafting has done. It has seemed to be very important to identify the mammary primary sarcomas as entity separated from the carcinomas of the breast.

Chondrosarcoma is the second most common primary mesenchymal malignant tumor of the bone. The most common form is central chondrosarcoma and the rarest is intracortical chondrosarcoma. Here, we describe the clinical, pathological, and imaging features of a case of intracortical chondrosarcoma as well as the outcome of surgical treatment. This is the third case reported in the literature.